Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 10, 2022

View Archived Issues

Down syndrome linked to senescence-like state

Identification of novel drug candidates targeting dengue virus capsid protein

Indirect radiolabeling of pGlu for intratumoral delivery of alpha- and beta-particle emitters

Novel roe-inspired MSC microcapsules for the treatment of IBD

Researchers publish data on DDR kinase inhibitor XBLJ-13 for pulmonary fibrosis

Tucatinib plus anti-HER2 antibody NSCs prolong survival of mice with brain-metastatic breast cancer

Dana-Farber Cancer Institute patents UCP1 activators

The Vanderbilt University divulges new muscarinic M5 receptor antagonists

Gossamer Bio presents DGKA and/or DGKZ inhibitors

Incyte synthesizes new JAK2 V617F inhibitors

Volastra Therapeutics identifies ENPP1 inhibitors

NHMRC grant supports exploration of Pharmaxis serine protease inhibitor for tissue repair

Bayer and Mammoth Biosciences enter collaboration and option agreement on Mammoth's CRISPR systems

MAP3K7 modulation to treat MDS-associated anemia

Pfizer and Beam Therapeutics collaborate to advance in vivo base editing programs

EsoCap and Upadia sign licensing agreement to develop therapeutics to treat Barrett's esophagus

Cullinan collaborates with Mount Sinai to develop HPK1 protein degraders for cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...